DAVENPORT, IOWA (November 13, 2023) — The Alzheimer’s Association announces a landmark $100 million investment into research initiatives in 2023. This unparalleled commitment stands as the largest single-year investment since the organization’s founding in 1980.

In 2023, the Alzheimer’s Association funded 271 scientific investigations from researchers at all career levels examining topics across the spectrum of dementia science. The Association’s global, cumulative impact on research now includes more than $360 million invested in over 1,000 active research projects in 53 countries, spanning six continents.

In Iowa, nearly $500,000 has been awarded to advance research efforts, and in Illinois, nearly $5 million has been awarded this year. This includes research being conducted in Iowa City, Iowa and Chicago and Urbana, Illinois.

In addition to research grant-funding, the Association’s investment in research supports a wide range of global leadership initiatives:

●      Global scientific/medical conferences, including the field’s largest and most prestigious event: The annual Alzheimer’s Association International Conference® (AAIC). Nearly 11,000 scientists attended AAIC 2023 from 110 countries.

●      Three influential peer-reviewed journals, including the flagship Alzheimer’s and Dementia: The Journal of the Alzheimer’s Association.

●      TrialMatch® — a free clinical studies matching service.

●      The Alzheimer’s Association International Society to Advance Alzheimer’s Research and Treatment (ISTAART) — an inclusive global network of more than 10,000 members representing over 120 countries.

Alzheimer’s is the sixth-leading cause of death in the United States. It kills more Americans than diabetes, and more than breast cancer and prostate cancer combined. More than six million Americans are living with Alzheimer’s disease, according to the Alzheimer’s Association 2023 Alzheimer’s Disease Facts and Figures. By 2050, the number of people with Alzheimer's is projected to increase to nearly thirteen million, barring the development of medical breakthroughs to prevent, slow, or stop the disease.

For more information, visit the Alzheimer’s Association at alz.org.

About the Alzheimer's Association

The Alzheimer’s Association is a worldwide voluntary health organization dedicated to Alzheimer’s care, support, and research. Our mission is to lead the way to end Alzheimer's and all other dementia — by accelerating global research, driving risk reduction and early detection, and maximizing quality care and support. Our vision is a world without Alzheimer's and all other dementia®. Visit alz.org or call 800.272.3900.

Support the River Cities' Reader

Get 12 Reader issues mailed monthly for $48/year.

Old School Subscription for Your Support

Get the printed Reader edition mailed to you (or anyone you want) first-class for 12 months for $48.
$24 goes to postage and handling, $24 goes to keeping the doors open!

Click this link to Old School Subscribe now.



Help Keep the Reader Alive and Free Since '93!

 

"We're the River Cities' Reader, and we've kept the Quad Cities' only independently owned newspaper alive and free since 1993.

So please help the Reader keep going with your one-time, monthly, or annual support. With your financial support the Reader can continue providing uncensored, non-scripted, and independent journalism alongside the Quad Cities' area's most comprehensive cultural coverage." - Todd McGreevy, Publisher